Clinical evaluation of the use of Piperacillin/Tazobactam in lower respiratory tract infection
Xiaofeng Liu
Abstract
Xiaofeng Liu
Abstract
Objective: To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection.Methods: 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group.Piperacillin/ Sulbactam was given to control group and Piperacillin/Tazobactam was given to treatment group.Results: The effective rates in the treatment group and control group were respectively 85.00% and 67.50%,and difference between the two groups was significant(P0.05).Piperacillin/Tazobactam group had the better clinical efficacy.Conclusion: Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better.It has lower adverse reactions,and should be popularize in clinic.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the clinical efficacy of Piperacillin/Tazobactam in treatment of lower respiratory tract infection.Methods: 80 cases of lower respiratory tract infection patients were divided into two groups with 40 cases in each group.Piperacillin/ Sulbactam was given to control group and Piperacillin/Tazobactam was given to treatment group.Results: The effective rates in the treatment group and control group were respectively 85.00% and 67.50%,and difference between the two groups was significant(P0.05).Piperacillin/Tazobactam group had the better clinical efficacy.Conclusion: Clinical efficacy of Piperacillin/Tazobactam used in lower respiratory tract infection patients is better.It has lower adverse reactions,and should be popularize in clinic.
Key concepts: Medicine, Piperacillin/tazobactam, Piperacillin, Tazobactam, Respiratory tract, Respiratory tract infections, Clinical efficacy, Sulbactam